Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2011-06-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2011-101815PMID 21368376PMCID PMC3572941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid load in nondemented brains correlates with APOE e4.

  2010cited by this paper
• A meta-analysis of cytokines in Alzheimer's disease.

  2010cited by this paper
• Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment: A Field in Its Infancy

  2010cited by this paper
• Differential Activation of Tumor Necrosis Factor Receptors Distinguishes between Brains from Alzheimer's Disease and Non-Demented Patients

  2010cited by this paper
• IL-32: a newly-discovered proinflammatory cytokine.

  2009cited by this paper
• Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Antagonist of peroxisome proliferator-activated receptor gamma induces cerebellar amyloid-beta levels and motor dysfunction in APP/PS1 transgenic mice.

  2009cited by this paper
• Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

  2009cited by this paper
• Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review

  2009influential reference
• The Role of Neuroimmunomodulation in Alzheimer's Disease

  2009cited by this paper
• Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients.

  2009influential reference
• Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

  2008cited by this paper
• Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.

  2008cited by this paper
• Protective effects of NSAIDs on the development of Alzheimer disease

  2008cited by this paper
• Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

  2008cited by this paper
• Inflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders

  2008cited by this paper
• Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.

  2008cited by this paper
• Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

  2008cited by this paper
• Induction of IL‐33 expression and activity in central nervous system glia

  2008cited by this paper
• LightCycler® 480 Real-Time PCR System

  2008cited by this paper
• Increased production of inflammatory cytokines in mild cognitive impairment.

  2007cited by this paper
• Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

  2007influential reference
• Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues.

  2007cited by this paper
• The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007

  2007cited by this paper
• Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.

  2007cited by this paper
• The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue.

  2007cited by this paper
• Anti-inflammatory and Immune Therapy for Alzheimer's Disease: Current Status and Future Directions

  2007cited by this paper
• Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.

  2007cited by this paper
• MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment

  2007cited by this paper
• Neuropathology of mild cognitive impairment

  2007cited by this paper
• Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.

  2007cited by this paper
• Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006cited by this paper
• Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia

  2006cited by this paper
• Regional Differences in Blood-Brain Barrier Permeability Changes and Inflammation in the Apathogenic Clearance of Virus from the Central Nervous System1

  2006cited by this paper
• Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

  2006cited by this paper
• Amyloid‐β induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease

  2005cited by this paper
• Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease.

  2005cited by this paper
• The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains.

  2004cited by this paper
• Beta-secretase activity increases with aging in human, monkey, and mouse brain.

  2004influential reference
• Tumor Necrosis Factor Death Receptor Signaling Cascade Is Required for Amyloid-β Protein-Induced Neuron Death

  2004cited by this paper
• Mild cognitive impairment as a diagnostic entity

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology.

  2003cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Neuroinflammation in Alzheimer's disease and prion disease

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002influential reference
• Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events.

  2001cited by this paper
• Interleukin-10 in the brain.

  2001cited by this paper
• Age‐ and concentration‐dependent neuroprotection and toxicity by TNF in cortical neurons from β‐amyloid

  2001cited by this paper
• Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form.

  2001cited by this paper
• Interleukin-1, neuroinflammation, and Alzheimer's disease.

  2001cited by this paper
• The role of TNF and its receptors in Alzheimer's disease.

  2001cited by this paper
• Chemokines and Alzheimer's disease.

  2001cited by this paper
• The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

  2000cited by this paper
• Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

  2000cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease

  1999influential reference
• Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.

  1998cited by this paper
• Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor*

  1998cited by this paper
• Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor.

  1998cited by this paper
• Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease?

  1997cited by this paper
• Atypical amyloid (A beta) deposition in the cerebellum in Alzheimer's disease: an immunohistochemical study using end-specific A beta monoclonal antibodies.

  1996cited by this paper
• Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.

  1996influential reference
• Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer’s disease: an immunohistochemical study using end-specific Aβ monoclonal antibodies

  1996cited by this paper
• Inflammation and Alzheimer's disease pathogenesis.

  1996cited by this paper
• Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.

  1994cited by this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  1993influential reference
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.

  1989cited by this paper
• Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

  1988cited by this paper

• Exercise Suppresses Insulin Resistance: A Potential Mechanism for Improving the Interaction Between Type 2 Diabetes and Alzheimer's Disease.

  2026cites this paper
• Oridonin Ameliorates Alzheimer's Disease-Like Pathology in Male Mice Through Inhibition of Receptor-Interacting Protein Kinase 1.

  2026cites this paper
• Deletion of NLRP3 gene blocks traumatic brain injury induced abnormal immune response in 3xTg AD mice

  2026cites this paper
• The Oral–Gut Microbiome–Brain Axis in Cognition

  2025cites this paper
• Therapeutic potential of dual HDAC6/SIRT2 inhibition in Alzheimer's disease.

  2025cites this paper
• Bridging the brain and gut: neuroimmune mechanisms of neuroinflammation and therapeutic insights

  2025cites this paper
• Studying the effect of Chlamydia trachomatis, Helicobacter pylori, and Varicella zoster microorganisms in stimulating the expression of cytokines TNFα, IFNɤ, TGFβ, IL-10 in Alzheimer and non-Alzheimer patients.

  2025cites this paper
• Polymeric Nanosystems: A Breakthrough Approach to Treating Inflammation and Inflammation Related Diseases

  2025cites this paper
• Alzheimer’s Disease Lipidome: Elevated Cortical Levels of Glycerolipids in Subjects with Mild Cognitive Impairment (MCI) but Not in Non-Demented Alzheimer’s Neuropathology (NDAN) Subjects

  2025cites this paper
• Zinc utilization by microglia in Alzheimer’s disease

  2024cites this paper
• Cerebral biomimetic nano-drug delivery systems: A frontier strategy for immunotherapy.

  2024cites this paper
• Early amyloid‐induced changes in microglia gene expression in male APP/PS1 mice

  2024cites this paper
• Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances

  2023cites this paper
• SIRT2 as a potential new therapeutic target for Alzheimer’s disease

  2023cites this paper
• Crosstalk between peripheral immunity and central nervous system in Alzheimer's disease.

  2023cites this paper
• IL-33/ST2 signaling pathway and Alzheimer's disease: A systematic review and meta-analysis.

  2023cites this paper
• mTOR signaling and Alzheimer's disease: What we know and where we are?

  2023cites this paper
• Glial Cells in Alzheimer's Disease: From Neuropathological Changes to Therapeutic Implications.

  2022cites this paper
• Hippocampal but Not Serum Cytokine Levels Are Altered by Traffic-Related Air Pollution in TgF344-AD and Wildtype Fischer 344 Rats in a Sex- and Age-Dependent Manner

  2022cites this paper
• Iron and Alzheimer’s Disease: From Pathology to Imaging

  2022cites this paper
• Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders.

  2022cites this paper
• Pin1 and Alzheimer's Disease.

  2022cites this paper
• Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.

  2022cites this paper
• Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases

  2022cites this paper
• Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases

  2022cites this paper
• Effect of amyloid-β on the redox system activity in SH-SY5Y cells preincubated with lipopolysaccharide or co-cultured with microglia cells.

  2022cites this paper
• Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease

  2021cites this paper
• Reduced TREM2 activation in microglia of patients with Alzheimer's disease

  2021cites this paper
• The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases

  2021cites this paper
• Alzheimer’s disease: a step closer to understanding type 3 diabetes in African Americans

  2021cites this paper
• Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis.

  2021cites this paper
• Normal aging, motor neurone disease, and Alzheimer’s disease are characterized by cortical changes in inflammatory cytokines

  2021cites this paper
• Context dependent cytokine secretion by stem cell derived microglia in vitro

  2020influential citation
• Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration

  2020cites this paper
• Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.

  2020cites this paper
• Combinatorial analyses reveal that cellular composition changes have different impact on transcriptomic changes of cell type specific genes in Alzheimer’s Disease brains

  2020cites this paper
• Combinatorial analyses reveal cellular composition changes have different impacts on transcriptomic changes of cell type specific genes in Alzheimer’s Disease

  2020cites this paper
• Short-term exposure to dietary cholesterol is associated with downregulation of interleukin-15, reduced thigmotaxis and memory impairment in mice.

  2020cites this paper
• Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases

  2020cites this paper
• Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer’s transgenic mice

  2020cites this paper
• Increased inflammation in BA21 brain tissue from African Americans with Alzheimer’s disease

  2019cites this paper
• Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury

  2019cites this paper
• Interplay between Mitophagy and Inflammasomes in Neurological Disorders.

  2019cites this paper
• The Role of Neuronal NLRP1 Inflammasome in Alzheimer’s Disease: Bringing Neurons into the Neuroinflammation Game

  2019cites this paper
• High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection

  2019cites this paper
• Human Glutaminyl Cyclase: Structure, Function, Inhibitors and Involvement in Alzheimer's Disease.

  2019cites this paper
• Alzheimer's disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes.

  2019cites this paper
• NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer’s Disease

  2019cites this paper
• Metabolic Syndrome and Its Biomarkers in the Development and Progression of Alzheimer’s Disease and Other Dementias

  2018cites this paper
• Aging exacerbates cognitive and anxiety alterations induced by an intracerebroventricular injection of amyloid‐&bgr;1–42 peptide in mice

  2018cites this paper
• Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling

  2018cites this paper
• Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain

  2018cites this paper
• Enhanced neuroinflammatory responses after systemic LPS injection in IL-32β transgenic mice.

  2018cites this paper
• Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits

  2018cites this paper
• TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer’s Disease and in Response to Hippocampal Deafferentation in Rodents

  2018cites this paper
• Blood Inflammatory Mediators and Cognitive Decline in Alzheimer’s Disease: A Two Years Longitudinal Study

  2018cites this paper
• Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.

  2018cites this paper
• Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience

  2018cites this paper
• Low-grade inflammation in the relationship between sleep disruption, dysfunctional adiposity, and cognitive decline in aging.

  2018cites this paper
• Elucidating the Interactive Roles of Glia in Alzheimer's Disease Using Established and Newly Developed Experimental Models

  2018cites this paper
• Inflammation as a Possible Link Between Dyslipidemia and Alzheimer's Disease.

  2018cites this paper
• Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy

  2017cites this paper
• Neuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity

  2017cites this paper
• Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimer's disease.

  2017cites this paper
• Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer’s disease: Alleviation by pantethine

  2017cites this paper
• Amyloidogenic proteins associated with neurodegenerative diseases activate the NLRP3 inflammasome

  2017cites this paper
• Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review

  2017cites this paper
• Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice

  2017cites this paper
• Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms

  2017cites this paper
• Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies

  2016cites this paper
• Docosahexaenoic Acid and Cognition throughout the Lifespan

  2016cites this paper
• The Brain-Body-Microbial Communities: A Crosstalk and Stress ExchangeBeyond the Gut hypothesis

  2016cites this paper
• Cytokine Therapies in Neurological Disease

  2016cites this paper
• Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer’s Disease

  2016influential citation
• Epistasis analysis links immune cascades and cerebral amyloidosis

  2015cites this paper
• Neuroinflammation in Alzheimer’s disease

  2015cites this paper
• Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer's Disease

  2015cites this paper
• Neuroinflammatory Signals in Alzheimer Disease and APP/PS1 Transgenic Mice: Correlations With Plaques, Tangles, and Oligomeric Species

  2015cites this paper
• β-amyloid, microglia, and the inflammasome in Alzheimer’s disease

  2015cites this paper
• Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

  2015cites this paper
• Medical diseases and obesity in major depressive disorder

  2015cites this paper
• Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

  2014cites this paper
• Distinctive RNA Expression Profiles in Blood Associated With Alzheimer Disease After Accounting for White Matter Hyperintensities

  2014cites this paper
• The endogenous α7 nicotinic acetylcholine receptor antagonist kynurenic acid modulates amyloid-β-induced inflammation in BV-2 microglial cells.

  2014cites this paper
• When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.

  2014cites this paper
• α1-antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity

  2014cites this paper
• Central and Peripheral Administration of Antisense Oligonucleotide Targeting Amyloid-β Protein Precursor Improves Learning and Memory and Reduces Neuroinflammatory Cytokines in Tg2576 (AβPPswe) Mice

  2014cites this paper
• Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations

  2014cites this paper
• Deciphering the mechanism underlying late-onset Alzheimer disease

  2013cites this paper
• The airbag problem–a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer’s disease

  2013cites this paper
• An integrated, fast and scalable approach for large-scale biological network analysis

  2013cites this paper
• Blood pro‐inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• The Neuroprotective Functions of Transforming Growth Factor Beta Proteins

  2012cites this paper
• Unveiling Clusters of RNA Transcript Pairs Associated with Markers of Alzheimer’s Disease Progression

  2012cites this paper
• Complement activation as a biomarker for Alzheimer's disease.

  2012cites this paper
• Roles of p75NTR in the pathogenesis of Alzheimer's disease: a novel therapeutic target.

  2011cites this paper
• World Journal of Diabetes

  year unknowncites this paper